Polymyalgia rheumatica is an inflammatory disorder manifested principally by stiffness of the
neck, shoulder girdle, and pelvic girdle; giant-cell (or temporal) arteritis affects the cranial …

Objective To evaluate the frequency of visual manifestations at presentation in an Italian
population‐based cohort of patients with biopsy‐proven giant cell arteritis (GCA), and to …

We studied the epidemiology of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR)
in a Mediterranean population. Ninety‐nine patients with PMR and/or GCA were identified …

Objective. Treatment of large-vessel vasculitis (LVV) remains challenging. Patients usually
respond to glucocorticoid (GC) therapy, but often relapse on tapering of the GC dose or after …

Objective: To determine the frequency and clinical features of patients with polymyalgia
rheumatica (PMR) and normal erythrocyte sedimentation rate (ESR) at diagnosis or during …

OBJECTIVE: Magnetic resonance imaging (MRI) showed that subacromial/subdeltoid
bursitis is the most frequent shoulder lesion in polymyalgia rheumatica (PMR). We evaluated …

Background: Evidence of a dark halo on ultrasonography has been considered a specific
sign of giant-cell arteritis and may replace temporal artery biopsy for the diagnosis of giant-cell …

Objective To determine laboratory parameters that may be useful in identifying polymyalgia
rheumatica (PMR) patients who require long‐term corticosteroid therapy. Methods A …

Background: A reliable alternative to steroids for treating polymyalgia rheumatica has not yet
been identified. Although infliximab has been used occasionally in steroid-resistant cases, …

We reviewed 888 temporal artery biopsies (TAB) performed in 871 patients in a single institution
from January 1986 to December 2013. Forty-four biopsies (4.9%) were inadequate, 490 …